Joseph Buckley
Gastroenterology · Indianapolis, INNPI 1710984877
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 425 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 27.1% of the total. Reporting peaked in 2021 at $2,641 and has fallen 99.1% since, to $25 in 2023.
Across 425 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$920
- Johnson & Johnson$396
- Gilead$391
- Redhill Biopharma Inc.$213
- plus $1K from 22 others
What the payments were for
- Food & beverage$6,554100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 102 | $1,776 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 87 | $1,506 |
| Takeda Pharmaceuticals U.S.A., Inc. | 63 | $920 |
| Johnson & Johnson | 39 | $396 |
| Gilead | 24 | $391 |
| Redhill Biopharma Inc. | 15 | $213 |
| UCB, Inc. | 15 | $210 |
| Pfizer | 13 | $189 |
| Ironwood Pharmaceuticals, Inc | 9 | $133 |
| Shire North American Group Inc | 16 | $122 |
| Merck | 6 | $91 |
| Daiichi Sankyo Inc. | 3 | $72 |
| Ferring Pharmaceuticals Inc. | 4 | $64 |
| Romark Laboratories, LC | 3 | $64 |
| Nestle Healthcare Nutrition Inc. | 4 | $62 |
| Bristol Myers Squibb | 4 | $57 |
| Braintree Laboratories, Inc. | 3 | $52 |
| Concordia Pharmaceuticals Inc. | 3 | $39 |
| QOL Medical, LLC | 2 | $32 |
| Intercept Pharmaceuticals, Inc. | 2 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Eisai Inc. | 1 | $24 |
| Tersera Therapeutics LLC | 1 | $23 |
| Sanofi | 1 | $22 |
| Oxford Immunotec USA Inc | 1 | $20 |
| Boston Scientific | 1 | $12 |
| Dova Pharmaceuticals | 1 | $11 |
| Micro-tech Endoscopy USA, Inc. | 1 | $10 |
How this compares
$6,565 in reported general payments places this provider in the 75th percentile of 323 gastroenterology providers in Indiana.
Other gastroenterology in Indianapolis
- Douglas RexIndianapolis$557K
- Ajay JainIndianapolis$432K
- Monika FischerIndianapolis$258K
- Naga ChalasaniIndianapolis$255K
- Thomas ImperialeIndianapolis$188K
- Mark GromskiIndianapolis$154K
- David PoundIndianapolis$137K
- Glen LehmanIndianapolis$87K
- Samer GawriehIndianapolis$78K
- Stuart ShermanIndianapolis$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.